The metabolic syndrome (syndrome X, insulin resistance syndrome) consists of a constellation of metabolic abnormalities that confer increased risk of cardiovascular disease (CVD) and diabetes mellitus (DM). The criteria for the metabolic syndrome have evolved since the original definition by the World Health Organization in 1998, reflecting growing clinical evidence and analysis by a variety of consensus conferences and professional organizations. The major features of the metabolic syndrome include central obesity, hypertriglyceridemia, low high-density lipoprotein (HDL) cholesterol, hyperglycemia, and hypertension (Table 32-1).
TABLE 32-1NCEP:ATPIII 2001 AND IDF CRITERIA FOR THE METABOLIC SYNDROME
The prevalence of metabolic syndrome varies around the world, in part reflecting the age and ethnicity of the populations studied and the diagnostic criteria applied. In general, the prevalence of metabolic syndrome increases with age. The highest recorded prevalence worldwide is in Native Americans, with nearly 60% of women ages 45–49 and 45% of men ages 45–49 meeting National Cholesterol Education Program and Adult Treatment Panel III (NCEP:ATPIII) criteria. In the United States, metabolic syndrome is less common in African-American men and more common in Mexican-American women. Based on data from the National Health and Nutrition Examination Survey (NHANES) 1999–2000, the age-adjusted prevalence of the metabolic syndrome in U.S. adults who did not have diabetes is 28% for men and 30% for women. In France, a cohort 30 to 60 years old has shown a <10% prevalence for each sex, although 17.5% are affected in the age range 60–64. Greater industrialization worldwide is associated with rising rates of obesity, which is anticipated to increase prevalence of the metabolic syndrome dramatically, especially as the population ages. Moreover, the rising prevalence and severity of obesity in children is initiating features of the metabolic syndrome in a younger population.
The frequency distribution of the five components of the syndrome for the U.S. population (NHANES III) is summarized in Fig. 32-1. Increases in waist circumference predominate in women, whereas fasting triglycerides >150 mg/dL and hypertension are more likely in men.
Prevalence of the metabolic syndrome components, from NHANES III. NHANES, National Health and Nutrition Examination Survey; TG, triglyceride; HDL, high-density lipoprotein; BP, blood pressure. The prevalence of elevated glucose includes individuals with known diabetes mellitus. (Created from data in ES Ford et al: Diabetes Care 27:2444, 2004.)
Although the first description of the metabolic syndrome occurred in the early twentieth century, the worldwide overweight/obesity epidemic has been the driving force for more recent recognition of the syndrome. Central adiposity is a key feature of the syndrome, reflecting the fact that the syndrome's prevalence is driven by the strong relationship between waist circumference and increasing adiposity. However, despite the importance of obesity, patients who are normal weight may also be insulin-resistant and have the syndrome.
Physical inactivity is a predictor of CVD events and related mortality rate. Many components of the metabolic syndrome are associated ...